Rewired type I IFN signaling is linked to age-dependent differences in COVID-19
Lev Petrov,Sophia Brumhard,Sebastian Wisniewski,Philipp Georg,David Hillus,Anna Hiller,Rosario Astaburuaga-Garcia,Nils Bluethgen,Emanuel Wyler,Katrin Vogt,Hannah-Philine Dey,Saskia von Stillfried,Christina Iwert,Roman D. Buelow,Bruno Maerkl,Lukas Maas,Christine Langner,Tim Meyer,Jennifer Loske,Roland Eils,Irina Lehmann,Benjamin Ondruschka,Markus Ralser,Jakob Trimpert,Peter Boor,Sammy Bedoui,Christian Meisel,Marcus A. Mall,Victor M. Corman,Leif Erik Sander,Jobst Roehmel,Birgit Sawitzki
DOI: https://doi.org/10.1101/2024.10.23.619479
2024-10-23
Abstract:Advanced age is the most important risk factor for severe disease or death from COVID-19, but a thorough mechanistic understanding of the molecular and cellular underpinnings is lacking. Multi-omics analysis of samples from SARS-CoV-2 infected persons aged 1 to 84 years, revealed a rewiring of type I interferon (IFN) signaling with a gradual shift from signal transducer and activator of transcription 1 (STAT1) to STAT3 activation in monocytes, CD4+ T cells and B cells with increasing age. Diversion of interferon IFN signaling was associated with increased expression of inflammatory markers, enhanced release of inflammatory cytokines, and delayed contraction of infection-induced CD4+ T cells. A shift from IFN-responsive germinal center B (GCB) cells towards CD69high GCB and atypical B cells corresponded to the formation of IgA in children while complement fixing IgG was dominant in adults. Our data provide a mechanistic basis for inflammation-prone responses to infections and associated pathology during aging.
Immunology